| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Estimating glomerular filtration rate from serum creatinine and cystatin C.
|
N Engl J Med
|
2012
|
14.99
|
|
2
|
Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program.
|
Clin Chem
|
2005
|
8.93
|
|
3
|
Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group.
|
Circ Cardiovasc Genet
|
2010
|
6.74
|
|
4
|
Hemochromatosis and iron-overload screening in a racially diverse population.
|
N Engl J Med
|
2005
|
5.78
|
|
5
|
Reporting genetic results in research studies: summary and recommendations of an NHLBI working group.
|
Am J Med Genet A
|
2006
|
4.56
|
|
6
|
Performance in Measurement of Serum Cystatin C by Laboratories Participating in the College of American Pathologists 2014 CYS Survey.
|
Arch Pathol Lab Med
|
2015
|
3.36
|
|
7
|
Leukocyte telomeres are longer in African Americans than in whites: the National Heart, Lung, and Blood Institute Family Heart Study and the Bogalusa Heart Study.
|
Aging Cell
|
2008
|
3.24
|
|
8
|
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
|
Arch Intern Med
|
2005
|
3.18
|
|
9
|
Cardiovascular outcomes in high-risk hypertensive patients stratified by baseline glomerular filtration rate.
|
Ann Intern Med
|
2006
|
2.81
|
|
10
|
Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes.
|
J Am Soc Nephrol
|
2012
|
2.75
|
|
11
|
Risk for ESRD in type 1 diabetes remains high despite renoprotection.
|
J Am Soc Nephrol
|
2011
|
2.50
|
|
12
|
Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial.
|
Hypertension
|
2012
|
2.42
|
|
13
|
Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study.
|
Am J Clin Nutr
|
2003
|
2.41
|
|
14
|
Roadmap for harmonization of clinical laboratory measurement procedures.
|
Clin Chem
|
2011
|
2.34
|
|
15
|
High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up.
|
Diabetes Care
|
2010
|
2.12
|
|
16
|
Dietary linolenic acid is inversely associated with calcified atherosclerotic plaque in the coronary arteries: the National Heart, Lung, and Blood Institute Family Heart Study.
|
Circulation
|
2005
|
2.03
|
|
17
|
Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study.
|
Am J Nephrol
|
2009
|
1.80
|
|
18
|
Hemochromatosis and Iron Overload Screening (HEIRS) study design for an evaluation of 100,000 primary care-based adults.
|
Am J Med Sci
|
2003
|
1.76
|
|
19
|
NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary.
|
J Nutr
|
2010
|
1.74
|
|
20
|
Biological variability of transferrin saturation and unsaturated iron-binding capacity.
|
Am J Med
|
2007
|
1.72
|
|
21
|
Genome scan of glomerular filtration rate and albuminuria: the HyperGEN study.
|
Nephrol Dial Transplant
|
2006
|
1.59
|
|
22
|
Pharmacogenetic association of hypertension candidate genes with fasting glucose in the GenHAT Study.
|
J Hypertens
|
2010
|
1.55
|
|
23
|
Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.
|
Am J Kidney Dis
|
2013
|
1.54
|
|
24
|
HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
|
Circ Cardiovasc Genet
|
2009
|
1.45
|
|
25
|
Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.
|
Circulation
|
2003
|
1.44
|
|
26
|
Biomarkers of vitamin B-12 status in NHANES: a roundtable summary.
|
Am J Clin Nutr
|
2011
|
1.43
|
|
27
|
Biomarkers of folate status in NHANES: a roundtable summary.
|
Am J Clin Nutr
|
2011
|
1.43
|
|
28
|
Alcohol consumption and metabolic syndrome: does the type of beverage matter?
|
Obes Res
|
2004
|
1.38
|
|
29
|
Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
|
Circulation
|
2005
|
1.30
|
|
30
|
Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension.
|
JAMA
|
2008
|
1.30
|
|
31
|
Discovery and fine mapping of serum protein loci through transethnic meta-analysis.
|
Am J Hum Genet
|
2012
|
1.29
|
|
32
|
An investigation of the effects of lipid-lowering medications: genome-wide linkage analysis of lipids in the HyperGEN study.
|
BMC Genet
|
2007
|
1.27
|
|
33
|
Serum concentration of cystatin C and risk of end-stage renal disease in diabetes.
|
Diabetes Care
|
2012
|
1.26
|
|
34
|
HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.
|
Transl Res
|
2008
|
1.20
|
|
35
|
Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening.
|
Can J Gastroenterol
|
2008
|
1.19
|
|
36
|
A genome-wide affected sibpair linkage analysis of hypertension: the HyperGEN network.
|
Am J Hypertens
|
2003
|
1.12
|
|
37
|
Serum ferritin and transferrin saturation in Asians and Pacific Islanders.
|
Arch Intern Med
|
2007
|
1.12
|
|
38
|
Interactions between the single nucleotide polymorphisms in the homocysteine pathway (MTHFR 677C>T, MTHFR 1298 A>C, and CBSins) and the efficacy of HMG-CoA reductase inhibitors in preventing cardiovascular disease in high-risk patients of hypertension: the GenHAT study.
|
Pharmacogenet Genomics
|
2008
|
1.12
|
|
39
|
Comparison of serum concentrations of β-trace protein, β2-microglobulin, cystatin C, and creatinine in the US population.
|
Clin J Am Soc Nephrol
|
2013
|
1.11
|
|
40
|
Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.
|
Clin Chem
|
2005
|
1.09
|
|
41
|
Association of low-grade albuminuria with adverse cardiac mechanics: findings from the hypertension genetic epidemiology network (HyperGEN) study.
|
Circulation
|
2013
|
1.07
|
|
42
|
Familial clustering for features of the metabolic syndrome: the National Heart, Lung, and Blood Institute (NHLBI) Family Heart Study.
|
Diabetes Care
|
2006
|
1.06
|
|
43
|
The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
|
Arch Intern Med
|
2004
|
1.06
|
|
44
|
Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations.
|
PLoS One
|
2012
|
1.03
|
|
45
|
Liver diseases in the hemochromatosis and iron overload screening study.
|
Clin Gastroenterol Hepatol
|
2006
|
1.02
|
|
46
|
Genome-wide association study identifies genetic loci associated with iron deficiency.
|
PLoS One
|
2011
|
1.01
|
|
47
|
Dietary linolenic acid is inversely associated with plasma triacylglycerol: the National Heart, Lung, and Blood Institute Family Heart Study.
|
Am J Clin Nutr
|
2003
|
1.01
|
|
48
|
Relation of the metabolic syndrome to calcified atherosclerotic plaque in the coronary arteries and aorta.
|
Am J Cardiol
|
2005
|
1.00
|
|
49
|
Effects of polymorphisms of methionine synthase and methionine synthase reductase on total plasma homocysteine in the NHLBI Family Heart Study.
|
Atherosclerosis
|
2003
|
0.98
|
|
50
|
Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population.
|
Am J Hematol
|
2008
|
0.98
|
|
51
|
HAMP promoter mutation nc.-153C>T in 785 HEIRS study participants.
|
Haematologica
|
2009
|
0.97
|
|
52
|
Circulating soluble ICAM-1 levels shows linkage to ICAM gene cluster region on chromosome 19: the NHLBI Family Heart Study follow-up examination.
|
Atherosclerosis
|
2007
|
0.97
|
|
53
|
Influence of apolipoprotein E, smoking, and alcohol intake on carotid atherosclerosis: National Heart, Lung, and Blood Institute Family Heart Study.
|
Stroke
|
2002
|
0.96
|
|
54
|
Association study of CRP gene polymorphisms with serum CRP level and cardiovascular risk in the NHLBI Family Heart Study.
|
Am J Physiol Heart Circ Physiol
|
2006
|
0.95
|
|
55
|
Screening for iron overload: lessons from the hemochromatosis and iron overload screening (HEIRS) study.
|
Can J Gastroenterol
|
2009
|
0.95
|
|
56
|
HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.
|
Am J Hematol
|
2009
|
0.94
|
|
57
|
Advances in standardization of laboratory measurement procedures: implications for measuring biomarkers of folate and vitamin B-12 status in NHANES.
|
Am J Clin Nutr
|
2011
|
0.94
|
|
58
|
Alcohol consumption and plasma atrial natriuretic peptide (from the HyperGEN study).
|
Am J Cardiol
|
2006
|
0.93
|
|
59
|
Heme carrier protein 1 (HCP1) genetic variants in the Hemochromatosis and Iron Overload Screening (HEIRS) Study participants.
|
Blood Cells Mol Dis
|
2009
|
0.92
|
|
60
|
Genetic and Adverse Health Outcome Associations with Treatment Resistant Hypertension in GenHAT.
|
Int J Hypertens
|
2013
|
0.92
|
|
61
|
A genome-wide screen reveals evidence for a locus on chromosome 11 influencing variation in LDL cholesterol in the NHLBI Family Heart Study.
|
Hum Genet
|
2002
|
0.91
|
|
62
|
The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13 ) on the effectiveness of statins: the GenHAT study.
|
Pharmacogenet Genomics
|
2009
|
0.91
|
|
63
|
Serum β-trace protein and risk of mortality in incident hemodialysis patients.
|
Clin J Am Soc Nephrol
|
2012
|
0.91
|
|
64
|
The effects of freeze-thaw on β-trace protein and β2-microglobulin assays after long-term sample storage.
|
Clin Biochem
|
2012
|
0.89
|
|
65
|
Probability of C282Y homozygosity decreases as liver transaminase activities increase in participants with hyperferritinemia in the hemochromatosis and iron overload screening study.
|
Hepatology
|
2012
|
0.89
|
|
66
|
Interarm differences in seated systolic and diastolic blood pressure: the Hypertension Genetic Epidemiology Network study.
|
J Hypertens
|
2005
|
0.89
|
|
67
|
Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS study initial screening.
|
Am J Hematol
|
2008
|
0.88
|
|
68
|
Pharmacogenetic effect of the stromelysin (MMP3) polymorphism on stroke risk in relation to antihypertensive treatment: the genetics of hypertension associated treatment study.
|
Stroke
|
2010
|
0.88
|
|
69
|
Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study.
|
PLoS One
|
2013
|
0.88
|
|
70
|
Pharmacogenetic associations of MMP9 and MMP12 variants with cardiovascular disease in patients with hypertension.
|
PLoS One
|
2011
|
0.87
|
|
71
|
Refined mapping of suggestive linkage to renal function in African Americans: the HyperGEN study.
|
Am J Hum Genet
|
2002
|
0.85
|
|
72
|
Dietary linolenic acid and fasting glucose and insulin: the National Heart, Lung, and Blood Institute Family Heart Study.
|
Obesity (Silver Spring)
|
2006
|
0.85
|
|
73
|
Vitamin D-Binding Protein Concentrations Quantified by Mass Spectrometry.
|
N Engl J Med
|
2015
|
0.84
|
|
74
|
Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study.
|
Thyroid
|
2008
|
0.83
|
|
75
|
Gene panels to help identify subgroups at high and low risk of coronary heart disease among those randomized to antihypertensive treatment: the GenHAT study.
|
Pharmacogenet Genomics
|
2012
|
0.83
|
|
76
|
Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study.
|
PLoS One
|
2012
|
0.83
|
|
77
|
Heritability of serum iron measures in the hemochromatosis and iron overload screening (HEIRS) family study.
|
Am J Hematol
|
2010
|
0.83
|
|
78
|
Association between celiac disease and iron deficiency in Caucasians, but not non-Caucasians.
|
Clin Gastroenterol Hepatol
|
2013
|
0.83
|
|
79
|
Dietary linolenic acid and adjusted QT and JT intervals in the National Heart, Lung, and Blood Institute Family Heart study.
|
J Am Coll Cardiol
|
2005
|
0.82
|
|
80
|
HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
|
Genet Test
|
2007
|
0.82
|
|
81
|
Exceptional memory performance in the Long Life Family Study.
|
Neurobiol Aging
|
2013
|
0.82
|
|
82
|
TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study.
|
Atherosclerosis
|
2004
|
0.82
|
|
83
|
Genome-wide linkage analysis replicates susceptibility locus for fasting plasma triglycerides: NHLBI Family Heart Study.
|
Hum Genet
|
2004
|
0.82
|
|
84
|
Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
|
Am Heart J
|
2007
|
0.81
|
|
85
|
Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
|
Transl Res
|
2006
|
0.80
|
|
86
|
Hemochromatosis (HFE) gene splice site mutation IVS5+1 G/A in North American Vietnamese with and without phenotypic evidence of iron overload.
|
Transl Res
|
2007
|
0.79
|
|
87
|
Comparison of cystatin C and creatinine-based equations for GFR estimation after living kidney donation.
|
Transplantation
|
2014
|
0.79
|
|
88
|
Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study.
|
Pharmacogenet Genomics
|
2009
|
0.78
|
|
89
|
Apolipoprotein E polymorphism modifies the alcohol-HDL association observed in the National Heart, Lung, and Blood Institute Family Heart Study.
|
Am J Clin Nutr
|
2004
|
0.78
|
|
90
|
Health-related quality of life in a racially diverse population screened for hemochromatosis: results from the Hemochromatosis and Iron Overload Screening (HEIRS) study.
|
Genet Med
|
2007
|
0.78
|
|
91
|
Segregation analysis of HDL cholesterol in the NHLBI Family Heart Study and in Utah pedigrees.
|
Eur J Hum Genet
|
2002
|
0.78
|
|
92
|
Estimated plasma stearoyl co-A desaturase-1 activity and risk of incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
|
Metabolism
|
2012
|
0.77
|
|
93
|
HFE mutations in Caucasian participants of the Hemochromatosis and Iron Overload Screening study with serum ferritin level <1000 µg/L.
|
Can J Gastroenterol
|
2013
|
0.77
|
|
94
|
Sex-specific effects of ACE I/D and AGT-M235T on pulse pressure: the HyperGEN Study.
|
Hum Genet
|
2007
|
0.77
|
|
95
|
Dietary iron intake and serum ferritin concentration in 213 patients homozygous for the HFEC282Y hemochromatosis mutation.
|
Can J Gastroenterol
|
2012
|
0.76
|
|
96
|
Comment on "Multidimensional results reporting to participants in genomic studies: getting it right".
|
Sci Transl Med
|
2011
|
0.76
|
|
97
|
Pharmacogenetic effects of 'candidate gene complexes' on stroke in the GenHAT study.
|
Pharmacogenet Genomics
|
2014
|
0.75
|
|
98
|
Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.
|
Blood Cells Mol Dis
|
2010
|
0.75
|
|
99
|
The association of cell cycle checkpoint 2 variants and kidney function: findings of the Family Blood Pressure Program and the Atherosclerosis Risk In Communities study.
|
Am J Hypertens
|
2009
|
0.75
|
|
100
|
Interlaboratory variation of plasma total homocysteine measurements: results of three successive homocysteine proficiency testing surveys.
|
Clin Chem
|
2002
|
0.75
|
|
101
|
Cystatin C enhances glomerular filtration rate estimating equations in kidney transplant recipients.
|
Am J Nephrol
|
2014
|
0.75
|